Annual CFO
-$125.18 M
-$365.00 K-0.29%
December 31, 2023
Summary
- As of February 7, 2025, BNGO annual cash flow from operations is -$125.18 million, with the most recent change of -$365.00 thousand (-0.29%) on December 31, 2023.
- During the last 3 years, BNGO annual CFO has fallen by -$86.87 million (-226.72%).
- BNGO annual CFO is now -527.67% below its all-time high of -$19.94 million, reached on December 31, 2018.
Performance
BNGO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$13.31 M
+$7.67 M+36.56%
September 1, 2024
Summary
- As of February 7, 2025, BNGO quarterly cash flow from operations is -$13.31 million, with the most recent change of +$7.67 million (+36.56%) on September 1, 2024.
- Over the past year, BNGO quarterly CFO has increased by +$16.47 million (+55.31%).
- BNGO quarterly CFO is now -373.80% below its all-time high of -$2.81 million, reached on December 31, 2017.
Performance
BNGO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$92.20 M
+$12.98 M+12.34%
September 1, 2024
Summary
- As of February 7, 2025, BNGO TTM cash flow from operations is -$92.20 million, with the most recent change of +$12.98 million (+12.34%) on September 1, 2024.
- Over the past year, BNGO TTM CFO has increased by +$32.98 million (+26.35%).
- BNGO TTM CFO is now -1151.72% below its all-time high of -$7.37 million, reached on March 31, 2017.
Performance
BNGO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BNGO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.3% | +55.3% | +26.4% |
| 3 y3 years | -226.7% | +59.0% | -1.9% |
| 5 y5 years | -527.7% | -84.4% | -188.9% |
BNGO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.0% | at low | at high | +63.7% | -28.2% | +30.7% |
| 5 y | 5-year | -323.9% | at low | -84.4% | +63.7% | -212.2% | +30.7% |
| alltime | all time | -527.7% | at low | -373.8% | +63.7% | -1151.7% | +30.7% |
Bionano Genomics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.31 M(-36.6%) | -$92.20 M(-12.3%) |
| Jun 2024 | - | -$20.98 M(-25.4%) | -$105.18 M(-13.0%) |
| Mar 2024 | - | -$28.13 M(-5.5%) | -$120.90 M(-3.4%) |
| Dec 2023 | -$125.18 M(+0.3%) | -$29.78 M(+13.3%) | -$125.18 M(-3.6%) |
| Sep 2023 | - | -$26.29 M(-28.3%) | -$129.92 M(-2.4%) |
| Jun 2023 | - | -$36.70 M(+13.2%) | -$133.10 M(+6.7%) |
| Mar 2023 | - | -$32.41 M(-6.1%) | -$124.73 M(-0.1%) |
| Dec 2022 | -$124.82 M(+73.5%) | -$34.52 M(+17.1%) | -$124.82 M(+7.7%) |
| Sep 2022 | - | -$29.47 M(+4.0%) | -$115.92 M(+8.9%) |
| Jun 2022 | - | -$28.33 M(-12.8%) | -$106.43 M(+17.6%) |
| Mar 2022 | - | -$32.49 M(+26.8%) | -$90.52 M(+25.8%) |
| Dec 2021 | -$71.93 M(+87.7%) | -$25.62 M(+28.2%) | -$71.93 M(+23.1%) |
| Sep 2021 | - | -$19.98 M(+60.9%) | -$58.41 M(+18.3%) |
| Jun 2021 | - | -$12.42 M(-10.7%) | -$49.39 M(+11.8%) |
| Mar 2021 | - | -$13.90 M(+14.9%) | -$44.19 M(+15.3%) |
| Dec 2020 | -$38.31 M | -$12.10 M(+10.4%) | -$38.31 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$10.96 M(+51.8%) | -$35.59 M(+11.5%) |
| Jun 2020 | - | -$7.22 M(-10.1%) | -$31.91 M(+2.9%) |
| Mar 2020 | - | -$8.03 M(-14.4%) | -$31.01 M(+5.0%) |
| Dec 2019 | -$29.53 M(+48.1%) | -$9.38 M(+28.9%) | -$29.53 M(+21.8%) |
| Sep 2019 | - | -$7.28 M(+15.3%) | -$24.24 M(+5.1%) |
| Jun 2019 | - | -$6.32 M(-3.6%) | -$23.06 M(+17.0%) |
| Mar 2019 | - | -$6.55 M(+60.2%) | -$19.71 M(-1.2%) |
| Dec 2018 | -$19.94 M(-4.2%) | -$4.09 M(-32.9%) | -$19.94 M(+6.9%) |
| Sep 2018 | - | -$6.10 M(+105.6%) | -$18.66 M(+2.4%) |
| Jun 2018 | - | -$2.97 M(-56.3%) | -$18.22 M(-10.0%) |
| Mar 2018 | - | -$6.79 M(+141.6%) | -$20.24 M(-2.8%) |
| Dec 2017 | -$20.82 M(-11.4%) | -$2.81 M(-50.3%) | -$20.82 M(+15.6%) |
| Sep 2017 | - | -$5.66 M(+13.4%) | -$18.01 M(+45.8%) |
| Jun 2017 | - | -$4.99 M(-32.3%) | -$12.35 M(+67.7%) |
| Mar 2017 | - | -$7.37 M | -$7.37 M |
| Dec 2016 | -$23.50 M | - | - |
FAQ
- What is Bionano Genomics annual cash flow from operations?
- What is the all time high annual CFO for Bionano Genomics?
- What is Bionano Genomics annual CFO year-on-year change?
- What is Bionano Genomics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bionano Genomics?
- What is Bionano Genomics quarterly CFO year-on-year change?
- What is Bionano Genomics TTM cash flow from operations?
- What is the all time high TTM CFO for Bionano Genomics?
- What is Bionano Genomics TTM CFO year-on-year change?
What is Bionano Genomics annual cash flow from operations?
The current annual CFO of BNGO is -$125.18 M
What is the all time high annual CFO for Bionano Genomics?
Bionano Genomics all-time high annual cash flow from operations is -$19.94 M
What is Bionano Genomics annual CFO year-on-year change?
Over the past year, BNGO annual cash flow from operations has changed by -$365.00 K (-0.29%)
What is Bionano Genomics quarterly cash flow from operations?
The current quarterly CFO of BNGO is -$13.31 M
What is the all time high quarterly CFO for Bionano Genomics?
Bionano Genomics all-time high quarterly cash flow from operations is -$2.81 M
What is Bionano Genomics quarterly CFO year-on-year change?
Over the past year, BNGO quarterly cash flow from operations has changed by +$16.47 M (+55.31%)
What is Bionano Genomics TTM cash flow from operations?
The current TTM CFO of BNGO is -$92.20 M
What is the all time high TTM CFO for Bionano Genomics?
Bionano Genomics all-time high TTM cash flow from operations is -$7.37 M
What is Bionano Genomics TTM CFO year-on-year change?
Over the past year, BNGO TTM cash flow from operations has changed by +$32.98 M (+26.35%)